(Q40261094)

19 September 2017

title

The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients (English)

1 reference

19 September 2017

0 references

Chung-Hua Hsu

1

1 reference

19 September 2017

Kung-Chang Hwang

2

1 reference

19 September 2017

Chung-Liang Chao

3

1 reference

19 September 2017

Steve G N Chang

4

1 reference

19 September 2017

Cheng-Chin Ker

5

1 reference

19 September 2017

Lin-Chen Chien

6

1 reference

19 September 2017

Mei-Shang Ho

7

1 reference

19 September 2017

Jaung-Geng Lin

8

1 reference

19 September 2017

Yi-Ming Chen

9

1 reference

19 September 2017

Pesus Chou

10

1 reference

19 September 2017

publication date

1 January 2006

1 reference

The American Journal of Chinese Medicine

19 September 2017

published in

1 reference

19 September 2017

volume

34

1 reference

19 September 2017

issue

6

1 reference

19 September 2017

page(s)

927-935

1 reference

Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

Coimmunization of Agaricus blazei Murill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

Guideline on management of severe acute respiratory syndrome (SARS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

Is traditional Chinese medicine useful in the treatment of SARS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

Profile of specific antibodies to the SARS-associated coronavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

Inhibition by Agaricus blazei Murill fractions of cytopathic effect induced by western equine encephalitis (WEE) virus on VERO cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

Development of a standard treatment protocol for severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

A cluster of cases of severe acute respiratory syndrome in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

H5N1 influenza pandemic: contingency plans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X06004405

10.1142/S0192415X06004405

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference